英文名 | 4-[5-Methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]aniline |
---|
分子式 | C11H10F3N3 |
---|---|
分子量 | 241.21200 |
精确质量 | 241.08300 |
PSA | 43.84000 |
LogP | 3.36290 |
海关编码 | 2933199090 |
---|
~97% 1006348-64-6 |
文献:CALCIMEDICA, INC.; CAO, Jianguo; WHITTEN, Jeffrey, P.; WANG, Zhijun; ROGERS, Evan; GREY, Jonathan Patent: WO2013/59666 A1, 2013 ; Location in patent: Paragraph 00656 ; |
~% 1006348-64-6 |
文献:CALCIMEDICA, INC.; CAO, Jianguo; WHITTEN, Jeffrey, P.; WANG, Zhijun; ROGERS, Evan; GREY, Jonathan Patent: WO2013/59666 A1, 2013 ; |
~% 1006348-64-6 |
文献:CALCIMEDICA, INC.; CAO, Jianguo; WHITTEN, Jeffrey, P.; WANG, Zhijun; ROGERS, Evan; GREY, Jonathan Patent: WO2013/59666 A1, 2013 ; |
海关编码 | 2933199090 |
---|---|
中文概述 | 2933199090. 其他结构上有非稠合吡唑环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |